Showing results (111-120 of 548) with videos related to
Sort By:
Pageof 55
Journal of Experimental Botany|October 10, 2017
Modification of meiotic recombination by natural variation in plantsEmma J Lawrence, Catherine H Griffin, Ian R HendersonBlood|July 11, 2000
The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sitesA J Gale, M J Heeb, J H GriffinInternational Journal of Hematology|April 6, 2012
Protein C anticoagulant and cytoprotective pathwaysJohn H Griffin, Berislav V Zlokovic, Laurent O MosnierJournal of Clinical Laboratory Analysis|January 1, 1995
Anticoagulant response to activated protein C: method validation and assay comparisonT Calkins, J Greengard, J H Griffin, et al.The Journal of Clinical Investigation|June 1, 1977
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogenS D Revak, C G Cochrane, J H GriffinThrombosis and Haemostasis|September 19, 2014
Cytoprotective-selective activated protein C therapy for ischaemic strokeLaurent O Mosnier, Berislav V Zlokovic, John H GriffinThe Journal of Biological Chemistry|December 25, 1991
Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activityR M Mesters, R A Houghten, J H GriffinPathophysiology of Haemostasis and Thrombosis|May 27, 2010
Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor VaThomas J Cramer, John H Griffin, Andrew J GalePacing and Clinical Electrophysiology : PACE|January 1, 1991
Balance and cognitive impairment in two epileptic patients before and after vagal nerve stimulationB M Clarke, A Upton, H Griffin, et al.Advances in Experimental Medicine and Biology|January 1, 1983
Immunochemical studies of human kininogenD M Kerbiriou, J H Griffin, M J LarrieuPageof 55